CoChat

The Case for Vancomycin as the Preferred Drug for Treatment of Clostridium difficile Infection

Bartlett, John G. · 2008 · Clinical Infectious Diseases
Cited by 90

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Antibiotic-associated diarrhea became a well-recognized complication of antibiotic use shortly after the introduction of these agents in the early 1950s. Staphylococcus aureus was the presumed pathogen, pseudomembraneous enterocolitis was the characteristic pathologic lesion, and oral vancomycin became the standard method of treatment [1–4]. In 1974, Tedesco et al. [4] published the seminal report on “clindamycin colitis,” showing a 10% rate of pseudomembraneous colitis associated with clindamycin use, but a notable observation in the study was that S. aureus, the presumed etiologic agent of this disease, could not be detected, despite the ease of growing it on selective media. This prompted subsequent studies to search for an alternative etiologic agent. Much of the early work was done with the hamster model, because clindamycin, as well as many other antibiotics, almost invariably caused a lethal cecitis that resembled the lesions found in patients. One of the first clues to a bacterial etiology in this model was the observation that clindamycin-induced disease could be prevented with oral vancomycin [5, 6]. The search for the alternative etiologic agent led to the detection of Clostridium difficile as the putative agent [7], and vancomycin was approved by the US Food and Drug Administration (FDA) for this indication; it quickly became standard therapy [8]. During the early 1980s, there were 3 important additional observations relevant to treatment: (1) the standard dose of vancomycin was reduced from 500 mg administered 4 times daily to 125 mg administered 4 times daily, (2) metronidazole appeared to be effective, and (3) both drugs were associated with relatively high rates of relapse after treatment was discontinued [8–12].

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/587654

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

Metadata

Authors
Bartlett, J. G.
Venue
Clinical Infectious Diseases
Published
2008-05-15
Volume
46
Issue
10
Pages
1489-1492
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2142802863
Cited by
90
References
1
FWCI
6.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.